Topical podcast discussions on current research and other key data tied to case presentations
Provided completely without charge or prerequisites
Delivered to your email inbox
Authored and peer-reviewed by expert faculty
Planned Topics - Volume 3:
EASL Coverage
AASLD Coverage
HCV Screening and Natural History
Treatment of HBV
HBV Cure
Non-Invasive Markers
Intended Audience
The target audience (clinicians) for this initiative includes: OB/GYNs, NPs, PAs, hepatologists, gastroenterologists, infectious disease physicians, community gastroenterologists and others who care for patients of Asian and West African descent in areas of high HBV prevalence.
Program Learning
Objectives After participating in this activity, the participant will demonstrate the ability to:
HCV
Identify and screen patients at risk for HCV
Describe new non-invasive techniques to stage liver disease
Interpret and apply best practices in identifying cirrhosis and HCC in patients infected with HCV
Recognize best practices in how to identify and manage HCV treatment-related side effects
Outline how newly emerging therapies apply to therapeutic decision-making in HCV infected and HIV/HCV co-infected patients
HBV
Identify and screen patients at risk for HBV
Describe new non-invasive techniques to stage liver disease
Interpret and apply best practices in identifying cirrhosis and HCC in patients infected with HBV
How do I earn CME credit?
For each newsletter issue, participants can earn 1.00 AMA PRA Category 1 Credit(s)™ and 0.5 AMA PRA Category 1 Credit(s)™ per podcast. Certificates are provided electronically from the Johns Hopkins School of Medicine.
